Q2

Welcome to the Brand page for “Q2”, which is offered here for Diagnostic preparations used to identify in a patient a genetic variation affecting drug action; pharmaceutical preparations for the treatment of cancer, proliferative diseases, inflammatory diseases, or cardiovascular diseases whose effect is related to the said genetic variation;.

Its status is currently believed to be active. Its class is unavailable. “Q2” is believed to be currently owned by “Variagenics, Inc.”